Menu
Back to User profile » Professor Giorgio L Colombo
Papers published by Professor Giorgio L Colombo:
Reduced adherence to antiretroviral therapy is associated with residual low-level viremia
Maggiolo F, Di Filippo E, Comi L, Callegaro A, Colombo GL, Di Matteo S, Valsecchi D, Rizzi M
Pragmatic and Observational Research 2017, 8:91-97
Published Date: 26 May 2017
Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers
Colombo GL, Cammà C, Attili AF, Ganga R, Gaeta GB, Brancaccio G, Franzini JM, Volpe M, Turchetti G
Therapeutics and Clinical Risk Management 2015, 11:1603-1612
Published Date: 19 October 2015
Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation
Maggiolo F, Colombo GL, Di Matteo S, Bruno GM, Astuti N, Di Filippo E, Masini G, Bernardini C
Patient Related Outcome Measures 2015, 6:53-60
Published Date: 17 February 2015
Economic and outcomes consequences of TachoSil®: a systematic review
Colombo GL, Bettoni D, Di Matteo S, Grumi C, Molon C, Spinelli D, Mauro G, Tarozzo A, Bruno GM
Vascular Health and Risk Management 2014, 10:569-576
Published Date: 10 September 2014
Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women
Papaleo E, Alviggi C, Colombo GL, Pisanelli C, Ripellino C, Longobardi S, Canonico PL
Therapeutics and Clinical Risk Management 2014, 10:479-484
Published Date: 25 June 2014
Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines
Colombo GL, Matteo SD, Antinori A, Medaglia M, Murachelli S, Rizzardini G
ClinicoEconomics and Outcomes Research 2013, 5:489-496
Published Date: 3 October 2013
A cost-of-illness study of spina bifida in Italy
Colombo GL, Di Matteo S, Vinci M, Gatti C, Pascali MP, De Gennaro M, Macrellino E, Mosiello G, Redaelli T, Schioppa F, Dieci C
ClinicoEconomics and Outcomes Research 2013, 5:309-316
Published Date: 2 July 2013
Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy
Ruggeri I, Bragato D, Colombo GL, Valla E, Di Matteo S
ClinicoEconomics and Outcomes Research 2012, 4:375-382
Published Date: 5 December 2012
Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy
Rizzardini G, Bonfanti P, Carenzi L, Coen M, Orlando G, Di Matteo S, Colombo GL
Therapeutics and Clinical Risk Management 2012, 8:377-384
Published Date: 17 September 2012
Antidiabetic therapy in real practice: indicators for adherence and treatment cost
Colombo GL, Rossi E, De Rosa M, Benedetto D, Gaddi AV
Patient Preference and Adherence 2012, 6:653-661
Published Date: 14 September 2012
Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation
Colombo GL, Di Matteo S, Bruno G, Girolomoni G, Vena GA
ClinicoEconomics and Outcomes Research 2012, 4:261-268
Published Date: 13 September 2012
Burden of Crohn’s disease: economics and quality of life aspects in Italy
Benedini V, Caporaso N, Corazza GR, Rossi Z, Fornaciari G, Cottone M, Frosini G, Caruggi M, Ottolini C, Colombo GL
ClinicoEconomics and Outcomes Research 2012, 4:209-218
Published Date: 24 July 2012
Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy
Colombo GL, Di Matteo S, Bruno G
Substance Abuse and Rehabilitation 2012, 3:73-79
Published Date: 17 July 2012
Cost-effectiveness analysis of initial HIV treatment under Italian guidelines
Colombo GL, Colangeli V, Di Biagio A, Di Matteo S, Viscoli C, Viale P
ClinicoEconomics and Outcomes Research 2011, 3:197-205
Published Date: 31 October 2011
Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
Giorgio L Colombo, Sergio Di Matteo, Maria Elisa Mancuso, et al
ClinicoEconomics and Outcomes Research 2011, 3:55-61
Published Date: 14 March 2011
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy
Giorgio L Colombo, Giovanni B Gaeta, Mauro Viganò, et al
ClinicoEconomics and Outcomes Research 2011, 3:37-46
Published Date: 15 February 2011
A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
Giorgio L Colombo, Sergio Di Matteo, Ketty Peris, Maria Concetta Fargnoli, et al.
ClinicoEconomics and Outcomes Research 2009, 1:53-59
Published Date: 15 October 2009
Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976
Colombo GL, Caruggi M, Di Matteo, et al
Neuropsychiatric Disease and Treatment 2008, 4:1283-1283
Published Date: 5 December 2008
Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis
V Nicosia, Giorgio Colombo, M Consentino, S Di Matteo, F Mika, et al
Therapeutics and Clinical Risk Management 2008, 4:1105-1110
Published Date: 10 October 2008
An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia
Giorgio L Colombo, Mauro Caruggi, Sergio Di Matteo, Alessandro Rossi
Neuropsychiatric Disease and Treatment 2008, 4:967-976
Published Date: 10 October 2008
Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
Giorgio L Colombo, Sergio Di Matteo, Lluis M Mir
Therapeutics and Clinical Risk Management 2008, 4:541-548
Published Date: 11 April 2008
Moderate and severe plaque psoriasis: cost-of-illness study in Italy
GL Colombo, GF Altomare, K Peris, P Martini, G Quarta
Therapeutics and Clinical Risk Management 2008, 4:559-568
Published Date: 11 April 2008
Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy
Giorgio L Colombo, Mauro Caruggi, Chiara Ottolini, Aldo P Maggioni
Vascular Health and Risk Management 2008, 4:223-234
Published Date: 8 February 2008